Bimiralisib (PQR309)
Bimiralisib (PQR309) is a novel brain-penetrant dual PI3K/mTOR inhibitor with in vitro and in vivo antilymphoma activity. It displays excellent selectivity versus PI3K-related lipid kinases, protein kinases and unrelated targets.
| Trivial name | N/A |
| Catalog Number | S8738 |
| CAS# | 1225037-39-7 |
| Size | 5mg |
| Supplier Page | http://www.selleckchem.com/products/pqr309-bimiralisib.html |
| Additional Information | https://file.selleck.cn/downloads/struct/pqr309-bimiralisib-chemical-structure-s8738.gif |